查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1732783

全球數位生物標記市場研究報告 - 產業分析、規模、佔有率、成長、趨勢及 2025 年至 2033 年預測

Global Digital Biomarkers Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 164 Pages | 商品交期: 最快1-2個工作天內

價格

全球數位生物標記市場規模預計將從 2024 年的 47.4 億美元成長到 2033 年的 303.2 億美元，在 2026 年至 2033 年的預測期內，年複合成長率(CAGR) 將達到 22.91%。

隨著技術進步推動健康監測和疾病管理創新解決方案的開發，數位生物標記市場正在迅速擴大。數位生物標記是透過數位設備收集的客觀、可量化的生理和行為資料，它正在改變醫療保健提供者評估患者健康和治療效果的方式。透過利用穿戴式裝置、行動應用程式和遠端監控工具，醫療保健專業人員可以即時了解患者​​狀況，從而提供更個人化和主動的護理。

此外，人工智慧和機器學習與數位生物標記分析的結合正在增強這些工具的準確性和預測能力。人工智慧演算法可以分析大量資料，以識別傳統方法可能無法發現的模式和相關性，從而能夠更早發現健康問題並採取更有效的干涉措施。這種向數據驅動的醫療保健的轉變使患者能夠積極地管理自己的健康，促進更大程度的參與和遵守治療計劃。

此外，對預防性醫療保健和慢性病管理的日益重視也推動了對數位生物標記的需求。隨著世界各地的醫療保健系統尋求降低成本和改善結果，遠端和持續監測健康指標的能力變得越來越有價值。數位生物標記可以促進及時干預，減少住院治療，並提高患者的整體生活品質。

我們的報告經過精心製作，為客戶提供有關各個行業和市場的全面且可行的見解。每份報告都包含幾個關鍵部分，以確保徹底了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入分析了領先公司的競爭動態和採用的關鍵策略。

市場預測：根據歷史資料和當前市場狀況，對特定時期內的市場規模和成長趨勢進行預測。這包括定量分析和圖形表示，以說明未來的市場軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供了對未來市場發展和成長前景的見解。

目錄

第1章：前言

  • 報告描述
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究流程
    • 市場研究方法

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第3章：數位生物標記產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按類型分析市場吸引力
    • 透過臨床實務進行市場吸引力分析
    • 按治療領域進行的市場吸引力分析
    • 按最終用途進行的市場吸引力分析
    • 市場吸引力分析：按地區

第4章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第5章：全球數位生物標記市場分析：按類型

  • 按類型概覽
  • 按類型分析歷史和預測數據
  • 穿戴
  • 基於行動的應用程式
  • 感應器
  • 其他

第6章：全球數位生物標記市場分析：按臨床實踐

  • 臨床實踐概述
  • 透過臨床實踐進行歷史和預測數據分析
  • 診斷數位生物標記
  • 監測數位生物標記
  • 預測和預後數位生物標記物
  • 其他

第7章：全球數位生物標記市場分析：按治療領域

  • 按治療領域概述
  • 按治療領域進行的歷史和預測數據分析
  • 心血管和代謝紊亂（CVMD）
  • 呼吸系統疾病
  • 精神障礙
  • 睡眠與運動疾病
  • 神經系統疾病
  • 肌肉骨骼疾病
  • 其他

第 8 章：全球數位生物標記市場分析：依最終用途

  • 按最終用途概述
  • 按最終用途進行的歷史和預測數據分析
  • 醫療保健公司
  • 醫療保健提供者
  • 付款人
  • 其他

第9章：全球數位生物標記市場分析：按地區

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測數據銷售分析
    • 北美各細分市場銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 歐洲各細分市場銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測數據銷售分析
    • 亞太地區分部銷售分析
    • 亞太地區國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 中東和非洲分部銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第10章：數位生物標記公司的競爭格局

  • 數位生物標記市場競爭
  • 夥伴關係/合作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Amgen Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Biogen Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • ActiGraph LLC
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • AliveCor Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Empatica Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • IXICO Plc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Neurotrack Technologies Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Clario
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Koneksa
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Huma
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Sonde Health Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Aural Analytics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Adherium Limited
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Imagene AI
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Brainomix
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

Product Code: VMR112111961

Global Digital Biomarkers Market size is anticipated to grow from USD 4.74 Billion in 2024 to USD 30.32 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 22.91% during the forecast period of 2026 to 2033.

The Digital Biomarkers Market is rapidly expanding as advancements in technology enable the development of innovative solutions for health monitoring and disease management. Digital biomarkers, which are objective, quantifiable physiological and behavioral data collected through digital devices, are transforming how healthcare providers assess patient health and treatment efficacy. By leveraging wearables, mobile applications, and remote monitoring tools, healthcare professionals can gain real-time insights into patient conditions, leading to more personalized and proactive care.

Moreover, the integration of artificial intelligence and machine learning into digital biomarker analysis is enhancing the accuracy and predictive capabilities of these tools. AI algorithms can analyze vast amounts of data to identify patterns and correlations that may not be apparent through traditional methods, enabling earlier detection of health issues and more effective interventions. This shift towards data-driven healthcare is empowering patients to take an active role in managing their health, fostering greater engagement and adherence to treatment plans.

Additionally, the growing emphasis on preventive healthcare and chronic disease management is driving demand for digital biomarkers. As healthcare systems worldwide seek to reduce costs and improve outcomes, the ability to monitor health metrics remotely and continuously is becoming increasingly valuable. Digital biomarkers can facilitate timely interventions, reduce hospitalizations, and enhance overall patient quality of life.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Type

  • Wearable
  • Mobile Based Applications
  • Sensors
  • Others

By Clinical Practice

  • Diagnostic Digital Biomarkers
  • Monitoring Digital Biomarkers
  • Predictive And Prognostic Digital Biomarkers
  • Other's

By Therapeutic Area

  • Cardiovascular And Metabolic Disorders (CVMD)
  • Respiratory Disorders
  • Psychiatric Disorders
  • Sleep & Movement Disease
  • Neurological Disorders
  • Musculoskeletal Disorders
  • Others

By End-use

  • Healthcare Companies
  • Healthcare Providers
  • Payers
  • Others
  • COMPANIES PROFILED
  • Amgen Inc.
  • Biogen Inc.
  • ActiGraph LLC
  • AliveCor Inc.
  • Empatica Inc.
  • IXICO plc
  • Neurotrack Technologies Inc.
  • Clario
  • Koneksa
  • Huma
  • Sonde Health Inc.
  • Aural Analytics
  • Adherium Limited
  • Imagene AI
  • Brainomix
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. DIGITAL BIOMARKERS INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Poerter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Clinical Practice
    • 3.7.3 Market Attractiveness Analysis By Therapeutic Area
    • 3.7.4 Market Attractiveness Analysis By End-use
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. Wearable Historic and Forecast Sales By Regions
  • 5.4. Mobile Based Applications Historic and Forecast Sales By Regions
  • 5.5. Sensors Historic and Forecast Sales By Regions
  • 5.6. Others Historic and Forecast Sales By Regions

6. GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY CLINICAL PRACTICE

  • 6.1. Overview By Clinical Practice
  • 6.2. Historical and Forecast Data Analysis By Clinical Practice
  • 6.3. Diagnostic Digital Biomarkers Historic and Forecast Sales By Regions
  • 6.4. Monitoring Digital Biomarkers Historic and Forecast Sales By Regions
  • 6.5. Predictive And Prognostic Digital Biomarkers Historic and Forecast Sales By Regions
  • 6.6. Other's Historic and Forecast Sales By Regions

7. GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY THERAPEUTIC AREA

  • 7.1. Overview By Therapeutic Area
  • 7.2. Historical and Forecast Data Analysis By Therapeutic Area
  • 7.3. Cardiovascular And Metabolic Disorders (CVMD) Historic and Forecast Sales By Regions
  • 7.4. Respiratory Disorders Historic and Forecast Sales By Regions
  • 7.5. Psychiatric Disorders Historic and Forecast Sales By Regions
  • 7.6. Sleep & Movement Disease Historic and Forecast Sales By Regions
  • 7.7. Neurological Disorders Historic and Forecast Sales By Regions
  • 7.8. Musculoskeletal Disorders Historic and Forecast Sales By Regions
  • 7.9. Others Historic and Forecast Sales By Regions

8. GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY END-USE

  • 8.1. Overview By End-use
  • 8.2. Historical and Forecast Data Analysis By End-use
  • 8.3. Healthcare Companies Historic and Forecast Sales By Regions
  • 8.4. Healthcare Providers Historic and Forecast Sales By Regions
  • 8.5. Payers Historic and Forecast Sales By Regions
  • 8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE DIGITAL BIOMARKERS COMPANIES

  • 10.1. Digital Biomarkers Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF DIGITAL BIOMARKERS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Amgen Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Biogen Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. ActiGraph LLC
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. AliveCor Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Empatica Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. IXICO Plc
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Neurotrack Technologies Inc.
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Clario
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Koneksa
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Huma
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Sonde Health Inc.
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Aural Analytics
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. Adherium Limited
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Imagene AI
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Brainomix
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Wearable Market Sales By Geography (USD MN)
  • Mobile Based Applications Market Sales By Geography (USD MN)
  • Sensors Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Clinical Practice (USD MN)
  • Diagnostic Digital Biomarkers Market Sales By Geography (USD MN)
  • Monitoring Digital Biomarkers Market Sales By Geography (USD MN)
  • Predictive And Prognostic Digital Biomarkers Market Sales By Geography (USD MN)
  • Other's Market Sales By Geography (USD MN)
  • Analysis By Therapeutic Area (USD MN)
  • Cardiovascular And Metabolic Disorders (CVMD) Market Sales By Geography (USD MN)
  • Respiratory Disorders Market Sales By Geography (USD MN)
  • Psychiatric Disorders Market Sales By Geography (USD MN)
  • Sleep & Movement Disease Market Sales By Geography (USD MN)
  • Neurological Disorders Market Sales By Geography (USD MN)
  • Musculoskeletal Disorders Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Healthcare Companies Market Sales By Geography (USD MN)
  • Healthcare Providers Market Sales By Geography (USD MN)
  • Payers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Digital Biomarkers Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Digital Biomarkers Report
  • Market Research Process
  • Market Research Methodology
  • Global Digital Biomarkers Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Clinical Practice
  • Market Attractiveness Analysis By Therapeutic Area
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Wearable Market Sales By Geography (USD MN)
  • Mobile Based Applications Market Sales By Geography (USD MN)
  • Sensors Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Clinical Practice (USD MN)
  • Diagnostic Digital Biomarkers Market Sales By Geography (USD MN)
  • Monitoring Digital Biomarkers Market Sales By Geography (USD MN)
  • Predictive And Prognostic Digital Biomarkers Market Sales By Geography (USD MN)
  • Other's Market Sales By Geography (USD MN)
  • Global Market Analysis By Therapeutic Area (USD MN)
  • Cardiovascular And Metabolic Disorders (CVMD) Market Sales By Geography (USD MN)
  • Respiratory Disorders Market Sales By Geography (USD MN)
  • Psychiatric Disorders Market Sales By Geography (USD MN)
  • Sleep & Movement Disease Market Sales By Geography (USD MN)
  • Neurological Disorders Market Sales By Geography (USD MN)
  • Musculoskeletal Disorders Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Healthcare Companies Market Sales By Geography (USD MN)
  • Healthcare Providers Market Sales By Geography (USD MN)
  • Payers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.